COVID-19, gender-based violence and health equity: Responding to the needs of individuals experiencing intimate violence in the context of a pandemic.

Health Equity, Learning Tools, Sex & Gender

The challenges related to the everyday lived experiences of intimate partner violence are magnified during times of crisis such as the pandemic we are facing today. In this talk, Dr. Karen Wood and Jo-Anne Dusel provide background on intimate partner violence in the context of the COVID-19 pandemic in order to engage participants in a discussion of how we, as caring members of our community, can work together to offer trauma-informed approaches when responding to the health needs of those at risk of gender-based violence. 


  • Karen Wood, RESOLVE Saskatchewan
  • Jo-Anne Dusel, Provincial Association of Transition Houses & Services of Saskatchewan (PATHS)

Take Your Learning Further:

  • Thank you to Dr. Karen Wood for generously compiling this pdf of resources related to COVID-19, gender-based violence and health equity, including where to get immediate support, information backgrounders, infographics and articles.
  • Listen to a recorded Q&A session with Karen Wood and Jo-Anne Dusel as a follow-up to this conversation
  • Explore this centralized hub for resources related to Gender-Based Violence (GBV) and the COVID-19 pandemic from the Centre for Research and Education on Violence Against Women & Children (CREVAWC)
  • Learn more about RESOLVE, a prairie-based research network that coordinates and supports research aimed at ending violence, especially violence involving girls and women.
  • Learn more about the Provincial Association of Transition Houses and Services of Saskatchewan (PATHS) a member association for 23 agencies that provide intimate partner violence services across Saskatchewan, including women’s shelters (also known as domestic violence shelters, safe shelters, transition houses, or interval houses), second stage shelters, and counselling centres that offer counselling and support to survivors of IPV.